Clinical and epidemiological aspects of schizotypal disorder in children and adolescents according to the Moscow psychiatric service

Abstract

BACKGROUND: Given the significant increase in the number of children and adolescents diagnosed with schizotypal disorder and the simultaneous decrease in the incidence of schizophrenia in recent years, studying possible causes of the tendency and provision of psychiatric care to these patients is necessary.

AIMS: To analyze the frequency of schizotypal disorder (F21) in children and adolescents and study the correspondence of diagnosis with the ICD-10 criteria and changes in accordance with disease dynamics to improve the continuity of psychiatric care.

MATERIALS AND METHODS: This retrospective observational study analyzed data of patients who underwent examination and treatment at Sukhareva Scientific and Practical Center for Child and Adolescent Mental Health between 1999 and 2019, and the inpatient and outpatient records of the center and outpatient records of psychoneurological clinics at the place of patients’ residence were analyzed.

RESULTS: The number of patients diagnosed with F21 schizotypal disorder increased along with the general increase in the number of patients (2812 people in 1999 and 5675 in 2019). They account for nearly half (48.3%) of the patients with diagnoses related to the schizophrenia spectrum (F2 schizophrenia and schizotypal and delusional disorders). Moreover, 71.2% of patients with F21 were diagnosed with F21.8 (schizotypal personality disorder). The number of patients diagnosed with schizophrenia decreased threefold, and the number of patients diagnosed with schizotypal disorder increased six-fold. Among those discharged with F21.8 diagnosis excluding rehospitalizations, 527 patients were selected for the clinical and follow-up study. After the exclusion of patients for various reasons, the patient cohort consisted of 139 patients who had been regularly followed up at psychoneurological clinics. The diagnoses with F2 code remained in 96% of 139 patients included in the cohort for the follow-up study, and only five patients had other disease codes. The diagnosis of schizotypal disorder (F21) persisted in 89 patients (64%).

CONCLUSION: The decrease in schizophrenia diagnoses and the increase in the diagnosis of schizotypal disorders in children and adolescents, as revealed in the clinical and epidemiological study of ICD-10 use in 20 years, require further in-depth studies of the possible causes of this transformation. In light of the forthcoming adaptation of ICD-11, unified and clear criteria must be developed for schizotypal disorders, and a common understanding of their nosological affiliation is needed to develop more advanced approaches to diagnosis. The organization of psychiatric care provision must be improved to ensure the continuity of inpatient and outpatient care, including non-state institutions.

Keywords

schizotypal disorder / schizophrenia spectrum / incidence / childhood and adolescence / diagnostics / ICD-10 / transitions of care

References

[1] McGorry PD, Mei C, Chanen A, et al. Designing and scaling up integrated youth mental health care. World Psychiatry. 2022;21(1): 61–76. doi: 10.1002/wps.20938

[2] McGorry P.D., Mei C., Chanen A., et al. Designing and scaling up integrated youth mental health care // World Psychiatry. 2022. Vol. 21, N 1. P. 61–76. doi: 10.1002/wps.20938

[3] Сaspi A, Houts RM, Ambler A, et al. Longitudinal assessment of mental health disorders and comorbidities across 4 decades among participants in the dunedin birth cohort study. JAMA Netw Open. 2020;3(4):e203221. doi: 10.1001/jamanetworkopen.2020.3221

[4] Сaspi A., Houts R.M., Ambler A., et al. Longitudinal assessment of mental health disorders and comorbidities across 4 decades among participants in the dunedin birth cohort study // JAMA Netw Open. 2020. Vol. 3, N 4. P. e203221. doi: 10.1001/jamanetworkopen.2020.3221

[5] Makushkin EV, Demcheva NK. Dynamics and comparative analysis of child and adolescent incidence of mental disorders in the Russian federation in the years 2000–2018. Russian Journal of Psychiatry. 2019;(4):4–15. (In Russ). doi: 10.24411/1560-957X-2019-11930

[6] Макушкин Е.В., Демчева Н.К. Динамика и сравнительный анализ детской и подростковой заболеваемости психическими расстройствами в Российской Федерации в 2000–2018 годах // Российский психиатрический журнал. 2019. № 4. С. 4–15. doi: 10.24411/1560-957X-2019-11930

[7] Pankova OF, Kazin NM, Ivanova SM. Schizophrenia spectrum disorders in children and adolescents: prevalence and diagnostics. Biomedical Journal of Pirogov University. 2021;(3):82–86. (In Russ). doi: 10.24075/vrgmu.2021.022

[8] Панкова О.Ф., Казин Н.М., Иванова С.М. Современные проблемы в изучении распространенности и диагностике расстройств шизофренического спектра у детей и подростков // Вестник Российского государственного медицинского университета. 2021. № 3. С. 82–86. doi: 10.24075/vrgmu.2021.022

[9] Pankova OF, Usacheva EL, Abramov AV, et al. Organizational issues relating to the inpatient psychiatric care of children and adolescents in the context of current trends. International Journal of Culture and Mental Health. 2018;11(1):75–86. doi: 10.1080/17542863.2017.1394665

[10] Pankova O.F., Usacheva E.L., Abramov A.V., et al. Organizational issues relating to the inpatient psychiatric care of children and adolescents in the context of current trends // International Journal of Culture and Mental Health. 2018. Vol. 11, N 1. P. 75–86. doi: 10.1080/17542863.2017.1394665

[11] Goryunov AV. History of the formation of views on schizotypal disorder in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(9):90–99. (In Russ). doi: 10.17116/jnevro202112109190

[12] Горюнов А.В. История формирования взглядов на шизотипическое расстройство в детско-подростковом возрасте // Журнал неврологии и психиатрии им. С.С. Корсакова. 2021. Т. 121, № 9. С. 90–99. doi: 10.17116/jnevro202112109190

[13] Suhareva GE. Klinicheskie lekcii po psihiatrii detskogo vozrasta. Vol. 1. Moscow; 1955. 458 p. (In Russ).

[14] Сухарева Г.Е. Клинические лекции по психиатрии детского возраста. Т. 1. Москва, 1955. 458 с.

[15] Simson TP. Shizofrenija rannego detskogo vozrasta. Moscow; 1948. 133 p. (In Russ).

[16] Симсон Т.П. Шизофрения раннего детского возраста. Москва, 1948. 133 с.

[17] Vrono MSh. Shizofrenija v detskom i podrostkovom vozraste. In: Rukovodstvo po psihiatrii v dvuh tomah. Moscow: Medicina; 1983. Vol. 1. P. 355–373. (In Russ).

[18] Вроно М.Ш. Шизофрения в детском и подростковом возрасте. В кн.: Руководство по психиатрии в двух томах. Москва : Медицина, 1983. Т. 1. С. 355–373.

[19] Bashina VM. Rannjaja detskaja shizofrenija. Moscow; 1989. (In Russ).

[20] Башина В.М. Ранняя детская шизофрения. Москва, 1989.

[21] Kozlova IA. Shizofrenija detskogo i podrostkovogo vozrasta. Rukovodstvo po psihiatrii. Moscow: Medicina; 1999. Vol. 2. P. 472–487. (In Russ).

[22] Козлова И.А. Шизофрения детского и подросткового возраста. Руководство по психиатрии. Москва : Медицина, 1999. Т. 2. С. 472–487.

[23] https://icd.who.int/en [Internet]. World Health Organization, ICD-10: International Statistical Classification of Diseases and Related Health Problems 10th Revision 1992. Available from: https://icd.who.int/en

[24] https://icd.who.int/en [Internet]. World Health Organization, ICD-10: International Statistical Classification of Diseases and Related Health Problems 10th Revision 1992. Доступ по ссылке: https://icd.who.int/en

[25] Churkin AA, Martjushov AN. Prakticheskoe rukovodstvo po primeneniju MKB-10 v psihiatrii i narkologii. Moscow: MegaPro; 2010. 132 p. (In Russ).

[26] Чуркин А.А., Мартюшов А.Н. Практическое руководство по применению МКБ-10 в психиатрии и наркологии. Москва : МегаПро, 2010. 132 с.

[27] Smulevich AB. Schizophrenia or a group of endogenous diseases? The past and the present. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(8):4–12. (In Russ). doi: 10.17116/jnevro2015115814-12

[28] Смулевич А.Б. Шизофрения или группа эндогенных заболеваний? История и современность // Журнал неврологии и психиатрии им. С.С. Корсакова. 2015. Т. 115, № 8. С. 4–12. doi: 10.17116/jnevro2015115814-12

[29] Meehl P. Schizotaxia, schizotypy, schizophrenia. American Psychologist. 1962;17(12):827. doi: 10.1037/h0041029

[30] Meehl P. Schizotaxia, schizotypy, schizophrenia // American Psychologist. 1962. Vol. 17, N 12. P. 827. doi: 10.1037/h0041029

[31] Neznanov NG, Martynihin IA, Mosolov SN. Diagnostika shizofrenii v Rossii: rezul’taty onlajn-oprosa vrachej-psihiatrov. Chast’ 1. Ispol’zovanie MKB-10. Sovremennaja terapija psihicheskih rasstrojstv. 2019;(1):2–19. (In Russ).

[32] Незнанов Н.Г., Мартынихин И.А., Мосолов С.Н. Диагностика шизофрении в России: результаты онлайн-опроса врачей-психиатров. Часть 1. Использование МКБ-10 // Современная терапия психических расстройств. 2019. № 1. С. 2–19.

[33] Kostyuk GP, Shmukler AB, Golubev SA. Epidemiological aspects of diagnosis of schizophrenia in Moscow. Russian Society of Psychiatrists. 2017;27(3):5–9. (In Russ).

[34] Костюк Г.П., Шмуклер А.Б., Голубев С.А. Эпидемиологические аспекты диагностики шизофрении в Москве // Социальная и клиническая психиатрия. 2017. Т. 27, № 3. С. 5–9.

[35] Morozov PV, Pavlichenko AV, Tochilov VA. Klassifikacii psihicheskih rasstrojstv. In: Psihiatrija. Nacional’noe rukovodstvo. 2-e izdanie, pererabotannoe i dopolnennoe. Moscow: “GJeOTAR-Media”; 2020. P. 210–241. (In Russ).

[36] Морозов П.В., Павличенко А.В., Точилов В.А. Классификации психических расстройств. В кн.: Психиатрия. Национальное руководство. 2-е издание, переработанное и дополненное. Москва : «ГЭОТАР-Медиа», 2020. С. 210–241.

[37] Westen D. Prototipnaja diagnostika psihiatricheskih sindromov. World Psychiatry. 2012;11(1):16–21. (In Russ).

[38] Westen D. Прототипная диагностика психиатрических синдромов // World Psychiatry. 2012. Т. 11, № 1. С. 16–21.

[39] Krueger RF, Markon KE. Na puti k klinicheski primenimoj i jempiricheski obosnovannoj dimensional’noj modeli psihopatologii. World Psychiatry. 2012;11(1):24–25. (In Russ).

[40] Krueger R.F., Markon K.E. На пути к клинически применимой и эмпирически обоснованной дименсиональной модели психопатологии // World Psychiatry. 2012. Т. 11, № 1. С. 24–25.

[41] First MB. Prakticheskaja sistema dlja prototipnoj diagnostiki v psihiatrii: klinicheskie opisanija i diagnosticheskie ukazanija MKB-11. World Psychiatry. 2012;11(1):26–27. (In Russ).

[42] First M.B. Практическая система для прототипной диагностики в психиатрии: клинические описания и диагностические указания МКБ-11 // World Psychiatry. 2012. Т. 11, № 1. С. 26–27.

[43] Lutova NB, Sorokin MY, Wied VD. Stigma in patients with mental disorders — its manifestations and consequences. V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2017;(3):41–45. (In Russ).

[44] Лутова Н.Б., Сорокин М.Ю., Вид В.Д. Психиатрическая стигма — ее проявления и последствия // Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2017. № 3. С. 41–45.

[45] Danilov DS. Therapeutic collaboration (compliance): content of the definition, mechanisms of formation, and methods of optimization. Neurology, Neuropsychiatry, Psychosomatics. 2014;(2):4–12. (In Russ).

[46] Данилов Д.С. Терапевтическое сотрудничество (комплаенс): содержание понятия, механизмы формирования и методы оптимизации // Неврология, нейропсихиатрия, психосоматика. 2014. № 2. С. 4–12.

[47] Trushkina SV. Present day challenges: medical compliance, partnership relationships, doctor’s communicative competence. Medicinskaja psihologija v Rossii. 2018;10(4):9. (In Russ).

[48] Трушкина С.В. Вызовы современности: медицинский комплаенс, партнерские отношения, коммуникативная компетентность врача // Медицинская психология в России. 2018. T. 10, № 4. C. 9.

RIGHTS & PERMISSIONS

Eco-Vector